Corporate News 23-Feb-23
Biocon redeems commercial paper of Rs 2250 cr
On 22 February 2023
Biocon has redeemed commercial paper of Rs 2250 crore on 22 February 2023.
Previous News
Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
( Hot Pursuit - 13-Nov-23 17:05 )
Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
( Hot Pursuit - 24-Jun-24 09:34 )
Biocon Ltd up for third straight session
( Hot Pursuit - 23-May-24 13:05 )
Biocon gets nod from SAHPRA for Tacrolimus capsules
( Hot Pursuit - 20-Apr-24 15:36 )
Board of Biocon recommends final dividend
( Corporate News - 16-May-24 17:54 )
Biocon Biologics set to introduce YESAFILI®, a proposed biosimilar to EYLEA® in Canadian market
( Corporate News - 04-Mar-24 09:30 )
Biocon to declare Quarterly Result
( Corporate News - 24-Apr-23 11:48 )
USFDA classifies inspection of Biocon Biologic's Malaysian unit as 'OAI'
( Corporate News - 18-Oct-23 09:28 )
Biocon Biologics divests its non-crore branded formulations biz in India
( Corporate News - 10-Nov-23 12:06 )
Biocon's API unit in Bangalore receives GMP compliance certificate
( Corporate News - 08-Jun-23 16:30 )
Biocon Ltd up for third consecutive session
( Hot Pursuit - 29-Sep-23 13:05 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
